|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 3049417 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14750672.9 |
| Date of filing the European patent application | 2014-07-30 | |
| (97) | Date of publication of the European application | 2016-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation | 2019-02-11 |
| (86) | Number | PCT/US2014/048810 |
| Date | 2014-07-30 |
| (87) | Number | WO 2015/017502 |
| Date | 2015-02-05 |
| (30) | Number | Date | Country code |
| 201361860401 P | 2013-07-31 | US |
| (72) |
LIU-BUJALSKI, Lesley, US
NGUYEN, Ngan, US
QIU, Hui, US
JONES, Reinaldo, US
MOCHALKIN, Igor, US
CALDWELL, Richard D., US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Piridinai, pirimidnai ir pirazinai kaip BTK inhibitoriai ir jų panaudojimas |
| PYRIDINES, PYRIMIDINES, AND PYRAZINES, AS BTK INHIBITORS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2020-06-26 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-07-30 |